Skip to main content
Han Zhu, MD, Cardiology, Stanford, CA

HanZhuMD

Cardiology • Stanford, CA

Assistant Professor/Cardiologist

Join to view full profile

Dr. Zhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Zhu's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2017 - 2020
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2014 - 2017
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2014

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingSTANFORD UNIVERSITY2024–2029
  • Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingSTANFORD UNIVERSITY2024–2029
  • Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingSTANFORD UNIVERSITY2024–2029
  • Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingSTANFORD UNIVERSITY2024–2029
  • Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingSTANFORD UNIVERSITY2024–2029
  • CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy MyocarditisSTANFORD UNIVERSITY2024–2026
  • CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy MyocarditisSTANFORD UNIVERSITY2024–2026
  • CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy MyocarditisSTANFORD UNIVERSITY2024–2026
  • CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy MyocarditisSTANFORD UNIVERSITY2024–2026
  • CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy MyocarditisSTANFORD UNIVERSITY2024–2026
  • Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced MyocarditisSTANFORD UNIVERSITY2022–2026
  • Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced MyocarditisSTANFORD UNIVERSITY2022–2026
  • Gene regulatory programs driving metabolic maturation ofhuman pluripotent stem cell derived beta-cellsUNIVERSITY OF COLORADO DENVER2024–2025
  • Gene regulatory programs drivingmetabolic maturation of human pluripotent stem cell derived β-cellsUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2025

Dr. Han Zhu, Dr. Han Zhu, MD, Dr. H Zhu